ValiRx plc (LON:VAL – Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1.61 ($0.02) and traded as low as GBX 0.74 ($0.01). ValiRx shares last traded at GBX 0.79 ($0.01), with a volume of 21,622,006 shares trading hands.
ValiRx Stock Performance
The stock’s 50 day moving average is GBX 0.97 and its two-hundred day moving average is GBX 1.61. The stock has a market capitalization of £1.04 million, a price-to-earnings ratio of -39.25 and a beta of 0.59. The company has a current ratio of 6.65, a quick ratio of 1.27 and a debt-to-equity ratio of 0.49.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- Golden Cross Stocks: Pattern, Examples and Charts
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Financial Services Stocks Investing
- 3 Steel Stocks Soaring After Tariff Announcements
- Trading Halts Explained
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.